Nuclear power startup X-energy saw strong investor demand on its first day of public trading following an upsized initial public offering on the Nasdaq.
X-energy's stock gained 27% in its trading debut, signaling robust appetite for the company's advanced nuclear technology solutions. The company completed an upsized IPO, expanding its offering to meet investor interest.
The strong opening reflects growing momentum in the nuclear sector as companies and governments explore advanced reactor designs to meet clean energy demands. X-energy focuses on next-generation nuclear technology aimed at delivering safer and more efficient power generation.
The IPO marks a significant milestone for the startup, which now gains access to public capital markets to fund research, development, and commercialization efforts. The company joins a growing list of nuclear technology firms pursuing public listings as the industry gains traction amid climate concerns and energy security discussions.
X-energy's debut performance indicates investor confidence in both the company's technology and the broader nuclear power sector's potential to play a larger role in global energy transition efforts.
Retro, a friend-focused photo-sharing app founded by former Instagram employees, has secured $21 million in Series A funding. The capital injection signals investor confidence in the social app's differentiated approach to photo sharing.
Sweden has built one of Europe's most vibrant startup ecosystems, drawing attention from investors and entrepreneurs across the continent. Cherry Ventures general partner Sophia Bendz breaks down the factors driving the Nordic nation's tech boom.
Metriport secured $26M in Series A and seed funding led by Matrix GP, bringing its total funding to $28.4M. The startup provides tools that enable doctors to retrieve and manage patient data.
Faro, an AI platform for clinical trial optimization, closed a $37.3 million Series B round co-led by Merck Global Health Innovation Fund and S32. The funding will support development of data models and AI tools designed to streamline trial processes.